Instead, this task has fallen to DARPA, which has managed to punch above its weight in delivering new medicines and vaccines. Yet America has lacked an agency devoted to radical health innovation. Improving clinical medicine requires bold thinking, a greater appetite for risk, and sustained commitment to goal-oriented research. ARPA-H will use emerging science to create new biotechnologies and medicines, just as DARPA has applied basic research in defense, communications, and other sectors. Earlier this month, Congress allocated $1 billion to establish the Advanced Research Projects Agency for Health (ARPA-H). Nonetheless, Biden has made up some lost ground with his proposal to create a new health agency modeled on the Defence Advanced Research Projects Agency (DARPA). Biden only recently named a commissioner of the Food and Drug Administration, and he has yet to fill many other key science-policy positions, including the office of the White House Science Adviser and the director of the National Institutes of Health (NIH). LONDON - Although US President Joe Biden promised to lead with “science and truth”, his administration’s efforts to advance science have fallen short.
0 kommentar(er)
